SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsArchive2026-11-16

Mon, Nov 16, 2026 - Page 45

8174 indexed SquawkNews stories from this UTC day. Showing 5281-5400.

EQUITY 4239EARNINGS 1763NEWS 316MACRO 256GEOPOLITICS 253MNA 237FX 219REGULATION 198CENTRAL_BANK 178COMMODITIES 169RATES 159ENERGY 131
L POET Technologies Inc. (POET) Q3 Revenue Rose 244% to $1.03M POET reported Q3 2026 revenue of $1.03M, up 244% year over year and 80% sequentially. Net loss narrowed to $7.6M from $9.4M a year earlier; quarter-end cash and short-term investments were $774.3M.Material DetailsContext EARNINGS | Nov 16, 2026, 12:07 PM UTC L Duke Robotics Names Avi Levin Chief Financial Officer EQUITY | Nov 16, 2026, 12:07 PM UTC M GXO Sees 2027 Organic Revenue Growth Above 5.5% EARNINGS | Nov 16, 2026, 12:07 PM UTC L POET Technologies Reports Record Q3 2026 Revenue of $1.03M, Up 244% Seventh consecutive quarter of sequential growth; loss per share improves to $(0.04) from $(0.07); $774.3 million in cash and short-term investmentsTORONTO, Nov. 16, 2026 (GLOBE NEWSWIRE) -- POET Technologies Inc. NASDAQ EARNINGS | Nov 16, 2026, 12:07 PM UTC M Prelude Therapeutics Reports Q3 Net Loss of $12.5 Million Prelude reported a Q3 net loss of $12.5 million, or $0.12 per share, compared with $19.7 million, or $0.26 per share, a year earlier. It had $142.7 million in cash, equivalents, restricted cash and marketable securities EQUITY | Nov 16, 2026, 12:07 PM UTC L Invivyd, Inc. (IVVD) Reports Q3 2026 Results; VYD2311 Data Update Expected Imminently Invivyd reported third-quarter 2026 results and business updates. The company said VYD2311 DECLARATION data and a regulatory update are expected imminently; the release text provided contains no financial figures.Materia EQUITY | Nov 16, 2026, 12:07 PM UTC L Unicycive Therapeutics, Inc. (UNCY) Reports $7.0M Q3 Net Loss; Cash Runway Beyond 2027 Unicycive reported a Q3 2026 net loss of $7.0M, or $0.25 per share, versus $6.0M, or $0.33 per share, in Q3 2025. Cash, cash equivalents and marketable securities were approximately $59M at September 30, with expected ru EQUITY | Nov 16, 2026, 12:07 PM UTC L Volkswagen Canada Marks Five Years of Game Changers Volkswagen Canada recognized five new Game Changers for contributions to local soccer communities. EQUITY | Nov 16, 2026, 12:07 PM UTC L Domino's Launches New Sweet Heat Smokehouse Pizza EQUITY | Nov 16, 2026, 12:07 PM UTC M Brazil's IBC-Br falls 0.2% in September Central bank data showed economic activity contracted 0.2% month over month, versus economists' forecast for a 0.29% decline. MACRO | Nov 16, 2026, 12:07 PM UTC L Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights NEW HAVEN, Conn., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. NASDAQ:IVVD today announced financial results for the third quarter ended September 30, 2026, and recent business highlights.“We are excited about the pro EQUITY | Nov 16, 2026, 12:07 PM UTC L Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update Enrollment of Phase 1 study of PRT13722, a first-in-class highly-selective oral KAT6A degrader in HR+ breast cancer is underway; initial proof of concept data anticipated in the 2nd half of 2027Entered into a clinical tr EQUITY | Nov 16, 2026, 12:07 PM UTC L Unicycive Therapeutics Announces Third Quarter 2026 Financial Results and Provides Business Update MOUNTAIN VIEW, Calif., Nov. 16, 2026 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) NASDAQ:UNCY, a biotechnology company developing therapies for patients with kidney disease, today annou EQUITY | Nov 16, 2026, 12:06 PM UTC L Matternet Names Ben Dobson CFO Matternet appointed Ben Dobson, formerly Joby’s finance head, as chief financial officer. EQUITY | Nov 16, 2026, 12:06 PM UTC M Bitcoin Falls Below $65,000 as CZ Cites Possible Factors Bitcoin lost support at $65,000. Binance co-founder Changpeng Zhao cited possible explanations including capital shifting toward Anthropic’s upcoming IPO, institutional withdrawals and security concerns, while cautioning CRYPTO | Nov 16, 2026, 12:06 PM UTC L Xtant Medical swings to Q3 net loss of $3.56 million from year-earlier profit; Q3 revenue falls 27% year over year to $24.29 million Xtant Medical swings to Q3 net loss of $3.56 million from year-earlier profit; Q3 revenue falls 27% EARNINGS | Nov 16, 2026, 12:06 PM UTC H XTANT MEDICAL HOLDINGS INC: NOT PROVIDING REVISED FULL-YEAR 2026 FINANCIAL GUIDANCE XTANT MEDICAL HOLDINGS INC: NOT PROVIDING REVISED FULL-YEAR 2026 FINANCIAL GUIDANCE EARNINGS | Nov 16, 2026, 12:06 PM UTC L Prelude Therapeutics: Cash Runway Into 2Q 2028 >PRLD Prelude Therapeutics: Cash Runway Into 2Q 2028 >PRLD EQUITY | Nov 16, 2026, 12:06 PM UTC H XTANT MEDICAL - NO LONGER EXPECTS TO ACHIEVE PREVIOUSLY ISSUED FULL-YEAR 2026 GUIDANCE XTANT MEDICAL - NO LONGER EXPECTS TO ACHIEVE PREVIOUSLY ISSUED FULL-YEAR 2026 GUIDANCE EARNINGS | Nov 16, 2026, 12:05 PM UTC L POET Technologies 3Q Loss/Shr 4c >POET POET Technologies 3Q Loss/Shr 4c >POET EQUITY | Nov 16, 2026, 12:05 PM UTC L Prelude Therapeutics 3Q Rev $5.65M >PRLD Prelude Therapeutics 3Q Rev $5.65M >PRLD EQUITY | Nov 16, 2026, 12:05 PM UTC L Unicycive Therapeutics 3Q Loss/Shr 25c >UNCY Unicycive Therapeutics 3Q Loss/Shr 25c >UNCY EQUITY | Nov 16, 2026, 12:05 PM UTC L Unicycive Therapeutics 3Q Loss $7M >UNCY Unicycive Therapeutics 3Q Loss $7M >UNCY EQUITY | Nov 16, 2026, 12:05 PM UTC H Tech stocks extended their selloff into a new week as traders reduced risky positions ahead of Nvidia’s earnings and Anthropic PBC’s expected market debut. Nasdaq 100 futures fell 0.8% after the index dropped 1.2% in the final session of last week, while S&P 500 futures slipped 0.3%. Tech stocks extended their selloff into a new week as traders reduced risky positions ahead of Nvidia’s earnings and Anthropic PBC’s expected market debut. Nasdaq 100 futures fell 0.8% after the index dropped 1.2% in the EARNINGS | Nov 16, 2026, 12:05 PM UTC M Belrise Industries shares surge 13% after Q2 results Belrise Industries shares rose 13% on Monday after the company reported Q2 FY27 results. The headline also cites an H-One merger and a 44% one-year stock rally. EQUITY | Nov 16, 2026, 12:05 PM UTC L Aker BP Completes LTIP Share Awards and Issues New Grants Aker BP finalised share awards under its 2023–2026 Long-Term Incentive Programme. EQUITY | Nov 16, 2026, 12:05 PM UTC L POET Technologies 3Q Rev $1.0M >POET POET Technologies 3Q Rev $1.0M >POET EQUITY | Nov 16, 2026, 12:05 PM UTC L Invivyd 3Q Loss/Shr 10c Vs. Loss 6c >IVVD Invivyd 3Q Loss/Shr 10c Vs. Loss 6c >IVVD EQUITY | Nov 16, 2026, 12:05 PM UTC L Instil Bio 3Q Loss/Shr 62c >TIL Instil Bio 3Q Loss/Shr 62c >TIL EQUITY | Nov 16, 2026, 12:05 PM UTC H Tech Slides & Nvidia Tests Loom - Europe Market Wrap Tech stocks extended their selloff into a new week as traders reduced risky positions ahead of Nvidia’s earnings and Anthropic PBC’s expected market debut. Nasdaq 100 futures fell 0.8% after the index dropped 1.2% in the CRYPTO | Nov 16, 2026, 12:05 PM UTC L Instil Bio 3Q Loss $4.23M >TIL Instil Bio 3Q Loss $4.23M >TIL EQUITY | Nov 16, 2026, 12:04 PM UTC L GT Biopharma 3Q Loss $3.5M >GTBP GT Biopharma 3Q Loss $3.5M >GTBP EQUITY | Nov 16, 2026, 12:04 PM UTC L Buffett to Convert 6,150 Berkshire Class A Shares Into 9,225,000 Class B Shares EQUITY | Nov 16, 2026, 12:04 PM UTC L JPMorgan Credit Card Delinquency Rate at 0.84% in October JPMorgan reported a credit card delinquency rate of 0.84% at the end of October. EQUITY | Nov 16, 2026, 12:04 PM UTC L Invivyd 3Q Rev $15.4M >IVVD Invivyd 3Q Rev $15.4M >IVVD EQUITY | Nov 16, 2026, 12:04 PM UTC L Buffett to Convert 6,150 Berkshire Class A Shares Into 9,225,000 Class B Shares EQUITY | Nov 16, 2026, 12:04 PM UTC L Deutsche Bank cuts Flowers Foods price target to $6 from $8 EQUITY | Nov 16, 2026, 12:04 PM UTC L Invivyd Appoints Marc W. Elia as CEO EQUITY | Nov 16, 2026, 12:04 PM UTC L AirJoule Technologies 3Q Loss/Shr 27c >AIRJ AirJoule Technologies 3Q Loss/Shr 27c >AIRJ EQUITY | Nov 16, 2026, 12:04 PM UTC L Diamondback boosts Permian presence with $5.03 billion deal for some Double Eagle units Diamondback Energy NASDAQ:FANG said on Monday it would buy certain units of Double Eagle in the Permian Basin for $5.03 billion in cash and stock, deepening its presence in the oil-rich region.The deal extends the US sha ENERGY | Nov 16, 2026, 12:04 PM UTC L CYPHERPUNK TECHNOLOGIES Q3 MINING REVENUE $9.9 MILLION CYPHERPUNK TECHNOLOGIES Q3 MINING REVENUE $9.9 MILLION EARNINGS | Nov 16, 2026, 12:04 PM UTC M Diamondback Agrees to $5.03 Billion Deal for Double Eagle Units Diamondback agreed to a $5.03 billion deal for some Double Eagle units, expanding its presence in the Permian. MNA | Nov 16, 2026, 12:04 PM UTC L Berkshire Hathaway: Warren E. Buffett, Chairman Emeritus, Will Convert 6,150 Class A Shares Into 9,225,000 Class B Shares Berkshire Hathaway: Warren E. Buffett, Chairman Emeritus, Will Convert 6,150 Class A Shares Into 9,225,000 Class B Shares EQUITY | Nov 16, 2026, 12:03 PM UTC L JPMorgan Reports October Credit Card Charge-Off Rate of 1.44% EQUITY | Nov 16, 2026, 12:03 PM UTC L Vycor Medical Reports Q3 Revenue of $414,895 and Nine-Month Revenue of $1.29 Million Vycor Medical reported revenue of $414,895 for the third quarter of 2026 and $1.29 million for the first nine months of the year. Gross profit was $353,017 for the quarter and $1.07 million year to date, while operating EARNINGS | Nov 16, 2026, 12:03 PM UTC L Elauwit Connection Q3 Revenue Rises 17% to $5.6 Million; Recurring Units Expand Elauwit Connection reported third-quarter 2026 revenue of $5.6 million, up 17% year over year, and a net loss of $2.6 million. Recurring service revenue increased 86% year over year to $1.5 million, while billed units gr EARNINGS | Nov 16, 2026, 12:03 PM UTC L Instil Bio Reports Q3 2026 Net Loss of $4.2 Million and $67.1 Million in Cash and Investments Instil Bio reported a third-quarter 2026 net loss of $4.2 million, or $0.62 per share, compared with a $13.6 million net loss a year earlier. The company ended September with $67.1 million in cash, restricted cash, marke EQUITY | Nov 16, 2026, 12:03 PM UTC L Broadridge and Coinbase Publish Onchain Shareholder Communications Standard The companies published a jointly developed open technical standard for delivering shareholder communications onchain. Broadridge also launched a data oracle. EQUITY | Nov 16, 2026, 12:03 PM UTC L Faeth Therapeutics Signs Roche Collaboration on Breast Cancer Study Faeth will sponsor and run a Phase 1b/2 study evaluating PIKTOR with Roche’s giredestrant in HR+/HER2- breast cancer. EQUITY | Nov 16, 2026, 12:03 PM UTC L Asian Stocks Close Mixed Asian markets finished mostly lower on Monday, with the Hang Seng higher. EQUITY | Nov 16, 2026, 12:03 PM UTC L Aramark Posts Higher Profit, Revenue on New Business, Improved Retention By Connor HartAramark reported higher profit and revenue in the latest quarter, as the company won new business and retained its existing customers.The food-services and facilities-management company posted a profit of $ EARNINGS | Nov 16, 2026, 12:03 PM UTC L AsiaFIN Turns to Q3 Net Loss of US$57,734; Q3 Revenue Falls 26% to US$1.17 Million AsiaFIN Turns to Q3 Net Loss of US$57,734; Q3 Revenue Falls 26% to US$1.17 Million AsiaFIN Holdi EARNINGS | Nov 16, 2026, 12:03 PM UTC L Buffett Donates 9,225,000 Berkshire Hathaway Class B Shares Warren E. Buffett donated 9,225,000 Class B shares, reducing his stake in Berkshire Hathaway. EQUITY | Nov 16, 2026, 12:02 PM UTC L Aker BP completes LTIP share awards and issues new grants Aker BP ASA finalised share awards under its 2023–2026 Long-Term Incentive Programme. EQUITY | Nov 16, 2026, 12:02 PM UTC L Helus Pharma (HELP) Reports Positive Phase 3 MDD Trial Results Helus Pharma reported HLP003 reduced MADRS scores versus placebo by 7.6 points at Week 6 and 7.0 points at Week 12 in the Phase 3 APPROACH trial; both differences were statistically significant (p<0.0001).Material Detail EQUITY | Nov 16, 2026, 12:02 PM UTC L Matternet Appoints Ben Dobson as CFO Ben Dobson joins from Joby Aviation, where he served as Head of Finance since 2021. EQUITY | Nov 16, 2026, 12:02 PM UTC M Macerich Acquires San Jose’s Oakridge Mall for About $250 Million EQUITY | Nov 16, 2026, 12:02 PM UTC H GXO Logistics, Inc. (GXO) Sets 2027 Outlook And 2030 Financial Targets GXO disclosed initial full-year 2027 financial outlook and 2030 targets for organic revenue CAGR, adjusted EBITA margin and free cash flow conversion. The target values are not stated in the provided release text.Materia EARNINGS | Nov 16, 2026, 12:02 PM UTC L AirJoule Technologies Reports Third Quarter 2026 Results and Provides Preliminary 2027 BitSink Outlook RONAN, Mont., Nov. 16, 2026 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation NASDAQ:AIRJ (“AIRJ” or the “Company”) today reported financial and operating results for the third quarter ended September 30, 2026.“This EQUITY | Nov 16, 2026, 12:02 PM UTC L Selkirk Copper Completes Phase 2 Drill Program Comprising 54,579 Metres in 223 Drill Holes and Reports Additional High-Grade Results from Fo HighlightsVancouver, British Columbia and Pelly Crossing, Yukon--(. - November 16, 2026) - Selkirk Copper Mines Inc. TSXV:SCMI (FSE: IO20) (OTCQX: SKRKF) ("Selkirk Copper" or the "Company") is pleased to announce complet COMMODITIES | Nov 16, 2026, 12:02 PM UTC L Rubicon Organics Inc. (ROMJ) Q3 Revenue Rose 17% to C$18.3M Q3 revenue was C$18.3M, up 17% year over year, and Adjusted EBITDA was C$1.4M. Cascadia generated approximately C$2.3M in its first full quarter of contribution; management expects continued revenue growth through the re EARNINGS | Nov 16, 2026, 12:02 PM UTC L AirJoule Technologies Corporation (AIRJ) Reports Q3 Results; BitSink Has $15M in Signed Orders AirJoule Technologies reported Q3 2026 results and preliminary 2027 BitSink outlook. BitSink had $15M in signed purchase orders; no prior-period comparison was provided.Material DetailsContext by AI AnalystThe report ref EQUITY | Nov 16, 2026, 12:02 PM UTC L Aben Gold Reports First Assay Results from the 2026 Drill Program Vancouver, BC, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Aben Gold Corp. (TSX-V: ABM) (OTCID: ABNAF) (Frankfurt: ML1) (“Aben” or “the Company”) is pleased to report initial assay results from diamond drill hole JN26-003, the fir COMMODITIES | Nov 16, 2026, 12:02 PM UTC L GT Biopharma, Inc. (GTBP) Reports $3.5M Q3 Net Loss GT Biopharma reported Q3 2026 net loss of approximately $3.5M, versus net income of $8.3M in Q3 2025; the prior-period result included $11.4M of non-cash income from a fair-value change. Cash of approximately $10M is exp EQUITY | Nov 16, 2026, 12:02 PM UTC L Helus Pharma Announces Positive Topline Results from Phase 3 APPROACH Study evaluating HLP003 as Adjunctive Treatment in Major Depressive Di HLP003 achieved statistically significant and clinically meaningful results in the primary and key secondary endpoints starting as early as Day 2 and maintained at all time points-7.6 point placebo-adjusted change from b EQUITY | Nov 16, 2026, 12:02 PM UTC L POET Technologies Names Giovanni Pacelli CFO Giovanni Pacelli will succeed Thomas Mika as CFO of POET Technologies. EQUITY | Nov 16, 2026, 12:02 PM UTC L Duke Robotics Corp. (DUKR) Q3 Revenue Rose 38% YoY; Cash Runway Expected Into 2028 Duke Robotics reported third-quarter revenue up 38% year over year. Cash and restricted cash were $6.5M at September 30, 2026, versus $750K at December 31, 2025; the company expects resources to support operations into 2 EARNINGS | Nov 16, 2026, 12:02 PM UTC L NextSource Materials Appoints Eugene Lee CFO Effective Dec. 1 Eugene Lee will succeed interim CFO Jaco Crouse, who has served in the role since March 2026. EQUITY | Nov 16, 2026, 12:02 PM UTC L AIRJOULE TECHNOLOGIES: AIRJ'S PRELIMINARY 2027 REVENUE OUTLOOK FOR BITSINK IS $15 MLN TO $20 MLN OF REVENUE IN 2027 AIRJOULE TECHNOLOGIES: AIRJ'S PRELIMINARY 2027 REVENUE OUTLOOK FOR BITSINK IS $15 MLN TO $20 MLN OF EARNINGS | Nov 16, 2026, 12:02 PM UTC L Rubicon Organics Reports Q3 2026 Financial Results VANCOUVER, British Columbia, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. TSXV:ROMJ OTCQX:ROMJF (“Rubicon Organics” or the “Company”), Canada’s leading licensed producer of premium cannabis products, announces EQUITY | Nov 16, 2026, 12:02 PM UTC L International Battery Metals Ltd. (IBAT) Posts $2.2M Q2 Net Income, Down 27% YoY For the three months ended September 30, 2026, revenue was $0 versus $64K a year earlier and net income was $2.2M versus $3.0M. The company reported an operating loss of $2.9M, compared with $3.4M.Material DetailsContext EARNINGS | Nov 16, 2026, 12:02 PM UTC L Lexeo Therapeutics Announces Positive Interim Phase I/II Data and Regulatory Update for LX2020 in PKP2 Arrhythmogenic Cardiomyopathy and Rep Participants in high-dose cohorts achieved 80% mean reduction in non-sustained ventricular tachycardia and 44% mean reduction in premature ventricular contractions at latest assessmentLX2020 generally well tolerated acro EQUITY | Nov 16, 2026, 12:02 PM UTC L BRIEF-Prelude Therapeutics Q3 EPS USD -0.12 Nov 16 (Reuters) - Prelude Therapeutics Q3 net income USD -12.544 million. EARNINGS | Nov 16, 2026, 12:02 PM UTC L BRIEF-Invivyd Q3 EPS USD -0.1 Nov 16 (Reuters) - Invivyd Q3 net income USD -33.468 million. EARNINGS | Nov 16, 2026, 12:02 PM UTC M Scotia Metals Secures Option to Acquire Nordestina Lithium Project Scotia Metals says it has secured an option to acquire 100% of the Nordestina Lithium Project in Brazil. The company also reports spodumene-bearing pegmatites mapped along a 3.3 km corridor. EQUITY | Nov 16, 2026, 12:02 PM UTC M Uber and Zoox to Launch in Los Angeles by End of 2026 EQUITY | Nov 16, 2026, 12:02 PM UTC L BRIEF-Prelude Therapeutics Q3 EPS USD -0.12 BRIEF-Prelude Therapeutics Q3 EPS USD -0.12 Nov 16 (Reuters) - Prelude Therapeutics Q3 net income US EARNINGS | Nov 16, 2026, 12:02 PM UTC L Sasquatch Resources Completes Acquisition of Echo Property Sasquatch Resources says it has closed its previously announced acquisition of the Echo Property, comprising eight mineral claims in British Columbia. MNA | Nov 16, 2026, 12:02 PM UTC L Uber Partners With Zoox to Offer Robotaxi Rides in Las Vegas Uber launched Zoox robotaxis on its platform in Las Vegas. EQUITY | Nov 16, 2026, 12:02 PM UTC L Instil Bio Reports Third Quarter 2026 Financial Results and Provides Corporate Update DALLAS, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Instil Bio, Inc. (“Instil”) NASDAQ:TIL, a biotechnology company building a portfolio of asset-focused subsidiaries to develop novel therapies for unmet medical needs, today repor EQUITY | Nov 16, 2026, 12:02 PM UTC L BRIEF-Invivyd Q3 EPS USD -0.1 BRIEF-Invivyd Q3 EPS USD -0.1 Nov 16 (Reuters) - Invivyd Q3 net income USD -33.468 million. Q3 reven EARNINGS | Nov 16, 2026, 12:02 PM UTC L GT Biopharma Reports Third Quarter 2026 Financial Results Phase 1 trial evaluating GTB-3650 TriKE® remains ongoing, with an update anticipated in Q4 2026Phase 1 basket trial evaluating GTB-5550 TriKE® in multiple solid tumor types known to express B7-H3 remains ongoing, with an EQUITY | Nov 16, 2026, 12:02 PM UTC M Falcon Energy Materials Closes 49% Weihai Stake Acquisition for $22M Falcon paid $22 million in cash for a 49% non-operating equity interest in Weihai. Weihai is profitable and has a 25,000 tpa CSPG production circuit. MNA | Nov 16, 2026, 12:02 PM UTC L Duke Robotics Reports Third Quarter 2026 Financial Results and Provides Business Update Commercial Expansion of IC Drone Platform into Greece Through Strategic Collaboration with CRONOS; Potential Large-Scale Projects Already Identified with the Potential to Represent Tens of Millions of Euros in Aggregate EQUITY | Nov 16, 2026, 12:02 PM UTC L Church & Dwight expects investment to add to cash earnings in 2027 EQUITY | Nov 16, 2026, 12:01 PM UTC L NextSource Materials Appoints Eugene Lee as Chief Financial Officer TORONTO, ON / / November 16, 2026 / NextSource Materials Inc. TSX:NEXTOTC:NSRCF ("NextSource" or the "Company") announces the appointment of Eugene Lee as Chief Financial Officer (CFO) of the Company, effective December EQUITY | Nov 16, 2026, 12:01 PM UTC H AIRJOULE TECHNOLOGIES: REAFFIRMED GUIDANCE FOR $27 MLN TO $28 MLN OF COMBINED AIRJ & AIRJOULE JOINT VENTURE CASH SPENDING IN 2026, EXCLUDING AIRJOULE TECHNOLOGIES: REAFFIRMED GUIDANCE FOR $27 MLN TO $28 MLN OF COMBINED AIRJ & AIRJOULE JOINT EARNINGS | Nov 16, 2026, 12:01 PM UTC L LEXEO THERAPEUTICS - Q3 2026 NET LOSS $38.30 MLN OR $0.43 PER SHARE VS $20.30 MLN OR $0.33 IN Q3 2025 LEXEO THERAPEUTICS - Q3 2026 NET LOSS $38.30 MLN OR $0.43 PER SHARE VS $20.30 MLN OR $0.33 IN Q3 202 EQUITY | Nov 16, 2026, 12:01 PM UTC L Railtown AI Demonstrates Siri Experiences Powered by Swift ADK Railtown AI says demonstrations show Siri connecting specialized AI agents, persistent knowledge and native Apple applications. EQUITY | Nov 16, 2026, 12:01 PM UTC L Church & Dwight Has Option to Buy Remaining 55% After Two Years MNA | Nov 16, 2026, 12:01 PM UTC L NABLUS SURGICAL CENTER Q3 OPERATING REVENUE JOD 2.1 MLN NABLUS SURGICAL CENTER Q3 OPERATING REVENUE JOD 2.1 MLN EARNINGS | Nov 16, 2026, 12:01 PM UTC L Aben Gold Reports First Assay Results from the 2026 Drill Program Vancouver, BC, Nov. 16, 2026 (GLOBE NEWSWIRE) -- Aben Gold Corp. COMMODITIES | Nov 16, 2026, 12:01 PM UTC L International Battery Metals Ltd. Reports Second Quarter of Fiscal Year 2027 Financial Results VANCOUVER, BC & HOUSTON, TX / / November 16, 2026 / International Battery Metals Ltd. ("IBAT" or the "Company") TSXV:IBATOTC:IBATF, an advanced technology provider of modular direct lithium extraction (DLE) systems, toda EQUITY | Nov 16, 2026, 12:01 PM UTC M Uber and Zoox Announce Multi-Year MGM Resorts Partnership Uber and Zoox announced a multi-year partnership with MGM Resorts in Las Vegas. EQUITY | Nov 16, 2026, 12:01 PM UTC L Lexeo Therapeutics 3Q Loss/Shr 43c >LXEO Lexeo Therapeutics 3Q Loss/Shr 43c >LXEO EQUITY | Nov 16, 2026, 12:01 PM UTC L AsiaFIN Holdings Corp. Announces Third Quarter 2026 Results, Reporting Strong Nine-Month Financial Performance with Improved Margins KUALA LUMPUR, MY / / November 16, 2026 / AsiaFIN Holdings Corp. OTC:ASFH, a global financial ecosystem enabler, today announced its financial results for the third quarter of 2026 ended September 30, 2026, reporting stro EARNINGS | Nov 16, 2026, 12:01 PM UTC L NABLUS SURGICAL CENTER Q3 NET PROFIT AFTER TAX JOD 111,808 NABLUS SURGICAL CENTER Q3 NET PROFIT AFTER TAX JOD 111,808 EARNINGS | Nov 16, 2026, 12:01 PM UTC L Falcon Energy Materials Closes Acquisition of 49% Interest in Weihai Falcon Energy Materials says it has closed its previously announced acquisition of a 49% strategic, non-operating equity interest in Weihai Hensen New… MNA | Nov 16, 2026, 12:01 PM UTC L GXO LOGISTICS - PRELIM 2027 OUTLOOK: >5.5% ORGANIC REVENUE GROWTH, >7.1% ADJ EBITDA MARGIN, >4.5% ADJ EBITA MARGIN GXO LOGISTICS - PRELIM 2027 OUTLOOK: >5.5% ORGANIC REVENUE GROWTH, >7.1% ADJ EBITDA MARGIN, >4.5% AD EARNINGS | Nov 16, 2026, 12:01 PM UTC M Church & Dwight to Buy 45% of Bali Treatment for $225 Million MNA | Nov 16, 2026, 12:01 PM UTC L Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights DECLARATION Phase 3 clinical trial data on VYD2311 (ibramvibart) to be available imminently, per the EQUITY | Nov 16, 2026, 12:01 PM UTC L Uber launches Zoox robotaxis in Las Vegas Uber launches Zoox fully autonomous robotaxis in Las Vegas. EQUITY | Nov 16, 2026, 12:01 PM UTC L Eloxx Pharmaceuticals, Inc. (ELOX) Reports $5.5M Q3 Net Loss; Cash Runway Into 2028 Eloxx reported a Q3 2026 net loss of $5.5M, versus $0.4M in Q3 2025, and cash of $56.3M at September 30, versus $62.0M at June 30. The company said cash is expected to fund operations into 2028.Material DetailsContext by EQUITY | Nov 16, 2026, 12:01 PM UTC L Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update Enrollment of Phase 1 study of PRT13722, a first-in-class highly-selective oral KAT6A degrader in HR EQUITY | Nov 16, 2026, 12:01 PM UTC L BRIEF-Cypherpunk Technologies Inc Q3 EPS USD 1.44 BRIEF-Cypherpunk Technologies Inc Q3 EPS USD 1.44 Nov 16 (Reuters) - Cypherpunk Technologies Inc Q3 EARNINGS | Nov 16, 2026, 12:01 PM UTC L BRIEF-Rubicon Organics Q3 Revenue CAD 18.3 Million BRIEF-Rubicon Organics Q3 Revenue CAD 18.3 Million Nov 16 (Reuters) - Rubicon Organics Q3 adjusted E EARNINGS | Nov 16, 2026, 12:01 PM UTC L INVIVYD Q3 NET INCOME USD -33.468 MILLION INVIVYD Q3 NET INCOME USD -33.468 MILLION FX | Nov 16, 2026, 12:01 PM UTC L INVIVYD Q3 EPS USD -0.1 INVIVYD Q3 EPS USD -0.1 EARNINGS | Nov 16, 2026, 12:01 PM UTC L BRIEF-Xtant Medical Q3 Revenue USD 24.3 Million BRIEF-Xtant Medical Q3 Revenue USD 24.3 Million Nov 16 (Reuters) - Xtant Medical Q3 net income USD EARNINGS | Nov 16, 2026, 12:01 PM UTC L INVIVYD REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS INVIVYD REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS EQUITY | Nov 16, 2026, 12:01 PM UTC L BRIEF-POET Technologies Q3 EPS USD -0.04 BRIEF-POET Technologies Q3 EPS USD -0.04 Nov 16 (Reuters) - POET Technologies Q3 net income USD -7.6 EARNINGS | Nov 16, 2026, 12:01 PM UTC L PRELUDE THERAPEUTICS Q3 EPS USD -0.12 PRELUDE THERAPEUTICS Q3 EPS USD -0.12 EARNINGS | Nov 16, 2026, 12:01 PM UTC L INVIVYD Q3 REVENUE USD 15.449 MILLION INVIVYD Q3 REVENUE USD 15.449 MILLION EARNINGS | Nov 16, 2026, 12:01 PM UTC L PRELUDE THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE PRELUDE THERAPEUTICS REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE EQUITY | Nov 16, 2026, 12:01 PM UTC L BRIEF-Instil Bio Q3 Basic EPS USD -0.62 BRIEF-Instil Bio Q3 Basic EPS USD -0.62 Nov 16 (Reuters) - Instil Bio Q3 operating expenses USD 5.98 EARNINGS | Nov 16, 2026, 12:01 PM UTC L PRELUDE THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -14.265 MILLION PRELUDE THERAPEUTICS Q3 INCOME FROM OPERATIONS USD -14.265 MILLION FX | Nov 16, 2026, 12:01 PM UTC L Lexeo Therapeutics 3Q Loss $38.3M >LXEO Lexeo Therapeutics 3Q Loss $38.3M >LXEO EQUITY | Nov 16, 2026, 12:01 PM UTC L Insight Enterprises Intends to Use Up to $100 Million for Stock Repurchases EQUITY | Nov 16, 2026, 12:01 PM UTC L Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights Invivyd Reports Third Quarter 2026 Financial Results and Recent Business Highlights DECLARATION Phas EQUITY | Nov 16, 2026, 12:01 PM UTC L Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update Prelude Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update Enro EQUITY | Nov 16, 2026, 12:01 PM UTC